These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1001 related items for PubMed ID: 26188656

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Screening for distant metastases before salvage surgery in patients with recurrent head and neck squamous cell carcinoma: a retrospective case series comparing thoraco-abdominal CT, positron emission tomography and abdominal ultrasound.
    Fakhry N, Michel J, Colavolpe C, Varoquaux A, Dessi P, Giovanni A.
    Clin Otolaryngol; 2012 Jun; 37(3):197-206. PubMed ID: 22520870
    [Abstract] [Full Text] [Related]

  • 24. Diagnostic Performance of Response Assessment FDG-PET/CECT in HNSCC Treated With Definitive Radio(chemo)therapy Using NI-RADS.
    Paul S, Gupta T, Purandare N, Joshi K, Ghosh-Laskar S, Budrukkar A, Swain M, Sinha S, Kumar A, Joshi A, Prabhash K, Nair S, Rangarajan V, Agarwal JP.
    Otolaryngol Head Neck Surg; 2023 Oct; 169(4):938-947. PubMed ID: 36856038
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Detection of neck recurrence in patients with differentiated thyroid cancer: comparison of ultrasound, contrast-enhanced CT and (18)F-FDG PET/CT using surgical pathology as a reference standard: (ultrasound vs. CT vs. (18)F-FDG PET/CT in recurrent thyroid cancer).
    Seo YL, Yoon DY, Baek S, Ku YJ, Rho YS, Chung EJ, Koh SH.
    Eur Radiol; 2012 Oct; 22(10):2246-54. PubMed ID: 22562091
    [Abstract] [Full Text] [Related]

  • 27. Improvement in the detection of locoregional recurrence in head and neck malignancies: F-18 fluorodeoxyglucose-positron emission tomography/computed tomography compared to high-resolution contrast-enhanced computed tomography and endoscopic examination.
    Rangaswamy B, Fardanesh MR, Genden EM, Park EE, Fatterpekar G, Patel Z, Kim J, Som PM, Kostakoglu L.
    Laryngoscope; 2013 Nov; 123(11):2664-9. PubMed ID: 23553147
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Diagnostic accuracy of ¹⁸F-FDG PET/CT for detection of suspected recurrence in patients with oesophageal carcinoma.
    Sharma P, Jain S, Karunanithi S, Pal S, Julka PK, Thulkar S, Malhotra A, Bal C, Kumar R.
    Eur J Nucl Med Mol Imaging; 2014 Jun; 41(6):1084-92. PubMed ID: 24435775
    [Abstract] [Full Text] [Related]

  • 30. Response evaluation of cervical lymph nodes after chemoradiation in patients with head and neck cancer - does additional [18F]FDG-PET-CT help?
    Dejaco D, Uprimny C, Widmann G, Riedl D, Moser P, Arnold C, Steinbichler TB, Kofler B, Schartinger VH, Virgolini I, Riechelmann H.
    Cancer Imaging; 2020 Sep 29; 20(1):69. PubMed ID: 32993805
    [Abstract] [Full Text] [Related]

  • 31. 18F-fluoro-deoxy-glucose-positron emission tomography/computed tomography in diagnosis of head and neck squamous cell carcinoma: a systematic review and meta-analysis.
    Rohde M, Dyrvig AK, Johansen J, Sørensen JA, Gerke O, Nielsen AL, Høilund-Carlsen PF, Godballe C.
    Eur J Cancer; 2014 Sep 29; 50(13):2271-9. PubMed ID: 25011659
    [Abstract] [Full Text] [Related]

  • 32. FDG-PET/CT as a post-treatment restaging tool in urothelial carcinoma: Comparison with contrast-enhanced CT.
    Kitajima K, Yamamoto S, Fukushima K, Yamakado K, Katsuura T, Igarashi Y, Kawanaka Y, Mouri M, Hirota S.
    Eur J Radiol; 2016 Mar 29; 85(3):593-8. PubMed ID: 26860672
    [Abstract] [Full Text] [Related]

  • 33. 18F-FDG PET/CT surveillance for the detection of recurrence in patients with head and neck cancer.
    Kim SA, Roh JL, Kim JS, Lee JH, Lee SH, Choi SH, Nam SY, Kim SY.
    Eur J Cancer; 2017 Feb 29; 72():62-70. PubMed ID: 28027517
    [Abstract] [Full Text] [Related]

  • 34. Clinical utility of 18F-FDG PET/CT for patients with recurrent head and neck squamous cell carcinoma.
    Ha SC, Roh JL, Kim JS, Lee JH, Choi SH, Nam SY, Kim SY.
    Acta Otolaryngol; 2019 Sep 29; 139(9):810-815. PubMed ID: 31274365
    [Abstract] [Full Text] [Related]

  • 35. Diagnostic Performance of 18F-FDG PET/CT According to Delay After Treatment to Detect Subclinical Recurrence of Head and Neck Squamous Cell Carcinoma.
    Clement C, Leclère JC, Maheo C, Le Pennec R, Le Gal G, Delcroix O, Robin P, Rousset J, Tissot V, Gueguen A, Allio M, Bourbonne V, Schick U, Marianowski R, Salaun PY, Abgral R.
    J Nucl Med; 2024 Aug 01; 65(8):1181-1187. PubMed ID: 38991750
    [Abstract] [Full Text] [Related]

  • 36. Diagnostic performance of FDG PET/CT to detect subclinical HNSCC recurrence 6 months after the end of treatment.
    Robin P, Abgral R, Valette G, Le Roux PY, Keromnes N, Rousset J, Potard G, Palard X, Marianowski R, Salaun PY.
    Eur J Nucl Med Mol Imaging; 2015 Jan 01; 42(1):72-8. PubMed ID: 25169701
    [Abstract] [Full Text] [Related]

  • 37. Interim FDG PET/CT for predicting the outcome in patients with head and neck cancer.
    Chen SW, Hsieh TC, Yen KY, Yang SN, Wang YC, Chien CR, Liang JA, Kao CH.
    Laryngoscope; 2014 Dec 01; 124(12):2732-8. PubMed ID: 25042474
    [Abstract] [Full Text] [Related]

  • 38. Performance of 18F-FDG PET/contrast-enhanced CT in the staging of squamous cell carcinoma of the oral cavity and oropharynx.
    Krabbe CA, Balink H, Roodenburg JL, Dol J, de Visscher JG.
    Int J Oral Maxillofac Surg; 2011 Nov 01; 40(11):1263-70. PubMed ID: 21824748
    [Abstract] [Full Text] [Related]

  • 39. Correlation between fluorodeoxyglucose hotspots on pretreatment positron emission tomography/CT and preferential sites of local relapse after chemoradiotherapy for head and neck squamous cell carcinoma.
    Chaput A, Calais J, Robin P, Thureau S, Bourhis D, Modzelewski R, Schick U, Vera P, Salaün PY, Abgral R.
    Head Neck; 2017 Jun 01; 39(6):1155-1165. PubMed ID: 28263422
    [Abstract] [Full Text] [Related]

  • 40. ¹⁸F-FDG PET/contrast enhanced CT in the standard surveillance of high risk colorectal cancer patients.
    Jiménez Londoño GA, García Vicente AM, Sánchez Pérez V, Jiménez Aragón F, León Martin A, Cano Cano JM, Domínguez Ferreras E, Gómez López OV, Espinosa Arranz J, Soriano Castrejón ÁM.
    Eur J Radiol; 2014 Dec 01; 83(12):2224-2230. PubMed ID: 25306106
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 51.